Petra Oliva

970 total citations
18 papers, 435 citations indexed

About

Petra Oliva is a scholar working on Physiology, Epidemiology and Molecular Biology. According to data from OpenAlex, Petra Oliva has authored 18 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Physiology, 6 papers in Epidemiology and 4 papers in Molecular Biology. Recurrent topics in Petra Oliva's work include Lysosomal Storage Disorders Research (14 papers), Cellular transport and secretion (4 papers) and Metabolism and Genetic Disorders (3 papers). Petra Oliva is often cited by papers focused on Lysosomal Storage Disorders Research (14 papers), Cellular transport and secretion (4 papers) and Metabolism and Genetic Disorders (3 papers). Petra Oliva collaborates with scholars based in United States, Austria and Canada. Petra Oliva's co-authors include Pavlina Wolf, Roy N. Alcalay, Guy A. Rouleau, Karen Marder, Stanley Fahn, Pietro Mazzoni, Wendy K. Chung, Cheryl Waters, Blair Ford and Oren Levy and has published in prestigious journals such as SHILAP Revista de lepidopterología, Brain and Neurology.

In The Last Decade

Petra Oliva

16 papers receiving 429 citations

Peers

Petra Oliva

PHYSI

NEURO

EPIDE

Nicholas Toker United States

Михаил Николаев Russia

Jenny Do United States

Emerson Maniwang United States

Gali Maor Israel

Alicia Lwin United States

Nandkishore R. Belur United States

Laura Smith United Kingdom

Marco Toffoli United Kingdom

Elina Makino United States

Nicholas Toker United States

Petra Oliva

261 ×0.8

PHYSI

273 ×1.0

NEURO

162 ×1.0

103 ×1.2

49 ×0.8

EPIDE

Citations per year, relative to Petra Oliva Petra Oliva (= 1×) peers Nicholas Toker

Countries citing papers authored by Petra Oliva

Since Specialization

Citations

This map shows the geographic impact of Petra Oliva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra Oliva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra Oliva more than expected).

Fields of papers citing papers by Petra Oliva

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra Oliva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra Oliva. The network helps show where Petra Oliva may publish in the future.

Co-authorship network of co-authors of Petra Oliva

This figure shows the co-authorship network connecting the top 25 collaborators of Petra Oliva. A scholar is included among the top collaborators of Petra Oliva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra Oliva. Petra Oliva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Basheeruddin, Khaja, Soumeya Bekri, Heather A. Brown, et al.. (2025). Newborn screening for metachromatic leukodystrophy: Preparation of reagents and methodology for measurement of sulfatides and arylsulfatase A enzymatic activity in dried blood spots. Molecular Genetics and Metabolism. 145(3). 109138–109138. 1 indexed citations

Vinatzer, Ursula, Michael P. Lux, Petra Oliva, et al.. (2024). Biochemical and Genetic Testing of GAA in Over 30.000 Symptomatic Patients Suspected to Be Affected With Pompe Disease. Human Mutation. 2024(1). 6248437–6248437.

Bekri, Soumeya, Annette Bley, Heather A. Brown, et al.. (2024). Higher precision, first tier newborn screening for metachromatic leukodystrophy using 16:1-OH-sulfatide. Molecular Genetics and Metabolism. 142(1). 108436–108436. 2 indexed citations

Oliva, Petra, Markus Schwarz, Thomas P. Mechtler, et al.. (2023). Importance to include differential diagnostics for acid sphingomyelinase deficiency (ASMD) in patients suspected to have to Gaucher disease. Molecular Genetics and Metabolism. 139(1). 107563–107563. 4 indexed citations

Oliva, Petra, et al.. (2023). A MLD newborn screening pilot-study for metachromatic leukodystrophy in Germany: Results of the first 12 months. Molecular Genetics and Metabolism. 138(2). 107249–107249. 1 indexed citations

Gelb, Michael H., Melissa Wasserstein, Joseph J. Orsini, et al.. (2023). Newborn screening for metachromatic leukodystrophy (MLD): An overview of ongoing and future studies. Molecular Genetics and Metabolism. 138(2). 107111–107111. 2 indexed citations

Wiesinger, Thomas, Markus Schwarz, Petra Oliva, et al.. (2021). Newborn screening for metachromatic leukodystrophy in Northern Germany- a prospective study. Molecular Genetics and Metabolism. 132(2). S112–S112. 3 indexed citations

Rotunno, Melissa, Wenfei Zhang, Pavlina Wolf, et al.. (2020). Cerebrospinal fluid proteomics implicates the granin family in Parkinson’s disease. Scientific Reports. 10(1). 2479–2479. 55 indexed citations

Oliva, Petra, Stefaan Sansen, Thomas P. Mechtler, et al.. (2020). Diagnostic strategy for females suspected of Fabry disease. Molecular Genetics and Metabolism. 129(2). S120–S120. 1 indexed citations

10.

Lukács, Zoltán, et al.. (2020). At-Risk Testing for Pompe Disease Using Dried Blood Spots: Lessons Learned for Newborn Screening. International Journal of Neonatal Screening. 6(4). 96–96. 1 indexed citations

11.

Oliva, Petra, Stefaan Sansen, Thomas P. Mechtler, et al.. (2019). Diagnostic strategy for females suspected of Fabry disease. Clinical Genetics. 97(4). 655–660. 21 indexed citations

12.

Shah, Harsh N., Christopher Liong, Oren Levy, et al.. (2018). Association of Low Lysosomal Enzymes Activity With Brain Arterial Dilatation. Stroke. 49(8). 1977–1980. 3 indexed citations

13.

Wolf, Pavlina, Roy N. Alcalay, Christopher Liong, et al.. (2017). Tandem mass spectrometry assay of β-glucocerebrosidase activity in dried blood spots eliminates false positives detected in fluorescence assay. Molecular Genetics and Metabolism. 123(2). 135–139. 11 indexed citations

14.

Alcalay, Roy N., Oren Levy, Pavlina Wolf, et al.. (2016). SCARB2 variants and glucocerebrosidase activity in Parkinson’s disease. npj Parkinson s Disease. 2(1). 31 indexed citations

15.

Chuang, Wei‐Lien, Joshua Pacheco, Samantha Cooper, et al.. (2015). Improved sensitivity of an acid sphingomyelinase activity assay using a C6:0 sphingomyelin substrate. SHILAP Revista de lepidopterología. 3. 55–57. 5 indexed citations

16.

Alcalay, Roy N., Oren Levy, Cheryl Waters, et al.. (2015). Glucocerebrosidase activity in Parkinson’s disease with and withoutGBAmutations. Brain. 138(9). 2648–2658. 287 indexed citations

17.

Alcalay, Roy N., Oren Levy, Cheryl Waters, et al.. (2015). Glucocerebrosidase activity in Parkinson disease with and without GBA mutations (S7.003). Neurology. 84(14_supplement). 2 indexed citations

18.

Mascellino, Maria Teresa, et al.. (1991). Evaluation of vaginal microflora in patients infected with HIV.. PubMed. 14(4). 343–9. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact